Related Experiment Video
Updated: Jan 18, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.2K
Recent and anticipated novel drug approvals (2Q 2025 through 1Q 2026)
Matthew H Rim1, Collin Dean1, Enela Aliaj1
1Northwestern Medicine, Chicago, IL, USA.
Summary
Pharmacists can prepare for upcoming novel drug approvals, focusing on therapies for rare diseases and cancer. This review highlights drugs with significant clinical and financial impact expected in 2025-2026.
Area of Science:
- Pharmaceutical Science
- Health Services Research
Background:
- Health-system pharmacists are vital for managing formularies and optimizing new therapies.
- Monitoring the pharmaceutical pipeline is essential for resource allocation and clinical program development.
Purpose of the Study:
- To provide health-system pharmacists with updates on new and anticipated novel drug approvals.
- To support informed decision-making regarding new therapeutic agents.
Main Methods:
- Review of selected novel drug approvals anticipated between Q2 2025 and Q1 2026.
- Analysis focused on drugs with expected significant clinical and financial impact in healthcare settings.
- Selection from 58 novel drugs awaiting US Food and Drug Administration (FDA) approval.
Main Results:
- The pharmaceutical pipeline includes novel therapies for rare diseases, targeted cancer treatments, and agents for various disease states.
- Anticipated approvals span a 12-month period, offering a forward look at therapeutic advancements.
- Emphasis on drugs poised to influence hospital and clinic practices.
Conclusions:
- Novel therapies are continuously enhancing the drug development pipeline.
- Pharmacists are key to integrating these advancements into patient care.
- The pipeline shows a strong trend toward specialized and targeted treatments.
Keywords:
Food and Drug Administration drug approvalclinical trialsdrug approval processinvestigational drugsmedication developmentnew drug approvalsMore Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.2K
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
873
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
245
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
245
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:26Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K
01:25Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
235
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
235
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
207
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
207